Diagnosis and endovascular management of vasospasm after aneurysmal subarachnoid hemorrhage — survey of real-life practices

Background Vasospasm and delayed cerebral ischemia (DCI) are the leading causes of morbidity and mortality after intracranial aneurysmal subarachnoid hemorrhage (aSAH). Vasospasm detection, prevention and management, especially endovascular management varies from center to center and lacks standardization. We aimed to evaluate this variability via an international survey of how neurointerventionalists approach vasospasm diagnosis and endovascular management. Methods We designed an anonymous online survey with 100 questions to evaluate practice patterns between December 2021 and September 2022. We contacted endovascular neurosurgeons, neuroradiologists and neurologists via email and via two professional societies – the Society of NeuroInterventional Surgery (SNIS) and the European Society of Minimally Invasive Neurological Therapy (ESMINT). We recorded the physicians’ responses to the survey questions. Results A total of 201 physicians (25% [50/201] USA and 75% non-USA) completed the survey over 10 months, 42% had >7 years of experience, 92% were male, median age was 40 (IQR 35–46). Both high-volume and low-volume centers were represented. Daily transcranial Doppler was the most common screening method (75%) for vasospasm. In cases of symptomatic vasospasm despite optimal medical management, endovascular treatment was directly considered by 58% of physicians. The most common reason to initiate endovascular treatment was clinical deficits associated with proven vasospasm/DCI in 89%. The choice of endovascular treatment and its efficacy was highly variable. Nimodipine was the most common first-line intra-arterial therapy (40%). Mechanical angioplasty was considered the most effective endovascular treatment by 65% of neurointerventionalists. Conclusion Our study highlights the considerable heterogeneity among the neurointerventional community regarding vasospasm diagnosis and endovascular management. Randomized trials and guidelines are needed to improve standard of care, determine optimal management approaches and track outcomes.

[1]  G. Meyfroidt,et al.  A Survey on Monitoring and Management of Cerebral Vasospasm and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: The Mantra Study. , 2023, Journal of neurosurgical anesthesiology.

[2]  W. Vandertop,et al.  Large practice variations in diagnosis and treatment of delayed cerebral ischemia after subarachnoid hemorrhage , 2022, World Neurosurgery.

[3]  V. Feigin,et al.  Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT). , 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[4]  C. Sherbourne,et al.  A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) , 2021, Journal of General Internal Medicine.

[5]  N. Ko,et al.  International Practice Variability in Treatment of Aneurysmal Subarachnoid Hemorrhage , 2021, Journal of clinical medicine.

[6]  J. Küchler,et al.  Non-compliant and compliant balloons for endovascular rescue therapy of cerebral vasospasm after spontaneous subarachnoid haemorrhage: experiences of a single-centre institution with radiological follow-up of the treated vessel segments , 2020, Stroke and vascular neurology.

[7]  Ching-Chang Chen,et al.  Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm , 2020, BMC Neurology.

[8]  T. Boppel,et al.  Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience , 2019, Clinical Neurology and Neurosurgery.

[9]  S. Froelich,et al.  Distal Balloon Angioplasty of Cerebral Vasospasm Decreases the Risk of Delayed Cerebral Infarction , 2019, American Journal of Neuroradiology.

[10]  J. Berkefeld,et al.  Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? , 2019, Journal of neuroradiology. Journal de neuroradiologie.

[11]  W. Chang,et al.  Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage , 2018, Journal of Korean Neurosurgical Society.

[12]  K. Bulsara,et al.  Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia. , 2015, World neurosurgery.

[13]  E. Connolly,et al.  Results of a national cerebrovascular neurosurgery survey on the management of cerebral vasospasm/delayed cerebral ischemia , 2014, Journal of NeuroInterventional Surgery.

[14]  Paul Vespa,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.

[15]  J. Mocco,et al.  Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. , 2011, World neurosurgery.

[16]  Giuseppe Citerio,et al.  Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference , 2011, Neurocritical care.

[17]  Joseph P Broderick,et al.  Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group , 2010, Stroke.

[18]  Oliver Rivero-Arias,et al.  Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom , 2010, Cost effectiveness and resource allocation : C/E.

[19]  P. Sandercock,et al.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion , 2005, The Lancet.

[20]  A. Algra,et al.  Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. , 1997, Stroke.

[21]  B. Weir,et al.  Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. , 1988, Journal of neurosurgery.

[22]  S. Achilefu,et al.  Department of radiology , 1955 .

[23]  Nicholas Dorsch,et al.  A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. , 2011, Acta neurochirurgica. Supplement.